MedTrace Logo

A Clinical Evaluation of the RheOx Bronchial Rheoplasty System

NCT05641207 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2025-06-26

No results posted yet for this study

Summary

This is a prospective, multicenter, single arm and open-label clinical trial to evaluate the performance, effectiveness and safety of RheOx™ system in the treatment of the symptoms of chronic bronchitis in adult moderate to severe COPD patients.

Conditions

Interventions

DEVICE

RheOx™ with the RheOx™ Catheter treated in the trial

Eligible patients be assigned two sessions of RheOx bronchial rheoplasty procedures * Treatment 1 is for the treatment of right lung * Treatment 2 is scheduled one month apart for left lung

Sponsors & Collaborators

  • Energenx Medical LTD.

    lead INDUSTRY

Principal Investigators

  • Guangfa WANG, MD · Peking University First Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
35 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-05-18
Primary Completion
2025-08-31
Completion
2025-11-30

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05641207 on ClinicalTrials.gov